Cytori Cell TherapyTM is under evaluation in the United States for treatment of patients with hand and finger involvement due to the autoimmune condition scleroderma, as well as patients with symptomatic knee osteoarthritis. Our technology is approved in many countries around the world, and we have a number of active global partnerships with academic hospitals, companies and government agencies that share our interest in bringing Cytori Cell TherapyTM to patients in need.